Dose escalation of ISB 1342, a novel CD38xCD3 bispecific antibody, in patients with relapsed / refractory multiple myeloma (RRMM) Meeting Abstract


Authors: Kapoor, P.; Stevens, D. A.; Leleu, X.; Merzoug, K. B.; Karlin, L.; Manier, S.; Chalopin, T.; Hulin, C.; Perrot, A.; Berdeja, J. G.; Chase, C. C.; Touzeau, C.; Moreau, P.; Mohan, S.; Lesokhin, A.; Huff, C.; Vesole, D. H.; Richter, J.; Matous, J.; Wolff, E.; Shah, T.; Koch-Olsen, J.; Garton, A.; Menon, V.; Gn, S.; Perro, M.; Zhukovsky, E.; Konto, C.; Pacaud, L.; Mohty, M.
Abstract Title: Dose escalation of ISB 1342, a novel CD38xCD3 bispecific antibody, in patients with relapsed / refractory multiple myeloma (RRMM)
Meeting Title: 65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 142
Issue: Suppl. 1
Meeting Dates: 2023 Dec 9-12
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2023-11-02
Start Page: 3339
Language: English
ACCESSION: WOS:001159740303202
DOI: 10.1182/blood-2023-186664
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Meyer Lesokhin
    363 Lesokhin